Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (201-210 of 453) with videos related to

Pageof 46
Sort By:
Neuro-Oncology Practice|March 9, 2026
The impact of neighborhood-level disadvantage on symptoms, mood, and health-related quality of life among the primary brain tumor populationZuena Karim, Kimberly Robins, Orieta Celiku, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.
American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03Christina Tsien, Jennifer Moughan, Jeff M Michalski, et al.
Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Cancer|June 23, 2021
Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017Diana R Withrow, Susan S Devesa, Dennis Deapen, et al.
Radiology|November 28, 2018
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 StudyDaniel P Barboriak, Zheng Zhang, Pratikkumar Desai, et al.
Journal of Neuro-Oncology|September 11, 2015
Primary and secondary gliosarcomas: clinical, molecular and survival characteristicsDavid Cachia, Carlos Kamiya-Matsuoka, Jacob J Mandel, et al.
Cancers|July 26, 2020
TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against GlioblastomaEmeline Tabouret, Herui Wang, Niranjana Amin, et al.
Neuro-Oncology|October 3, 2002
Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategiesFrederick F Lang, Mark R Gilbert, Vinay K Puduvalli, et al.
Pageof 46

Showing results (201-210 of 453) with videos related to

Sort By:
Pageof 46
Neuro-Oncology Practice|March 9, 2026
The impact of neighborhood-level disadvantage on symptoms, mood, and health-related quality of life among the primary brain tumor populationZuena Karim, Kimberly Robins, Orieta Celiku, et al.
Neuro-Oncology|February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.
American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03Christina Tsien, Jennifer Moughan, Jeff M Michalski, et al.
Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Cancer|June 23, 2021
Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017Diana R Withrow, Susan S Devesa, Dennis Deapen, et al.
Radiology|November 28, 2018
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 StudyDaniel P Barboriak, Zheng Zhang, Pratikkumar Desai, et al.
Journal of Neuro-Oncology|September 11, 2015
Primary and secondary gliosarcomas: clinical, molecular and survival characteristicsDavid Cachia, Carlos Kamiya-Matsuoka, Jacob J Mandel, et al.
Cancers|July 26, 2020
TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against GlioblastomaEmeline Tabouret, Herui Wang, Niranjana Amin, et al.
Neuro-Oncology|October 3, 2002
Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategiesFrederick F Lang, Mark R Gilbert, Vinay K Puduvalli, et al.
Pageof 46